2,354
Views
119
CrossRef citations to date
0
Altmetric
Review

The cannabis withdrawal syndrome: current insights

&
Pages 9-37 | Published online: 27 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Mayra Cruz Preto, Guilherme Trevizan Kortas, Israel Kanaan Blaas, Dangela Layne Silva Lassi, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Cintia de Azevedo-Marques Périco, Arthur Guerra de Andrade & João Mauricio Castaldelli-Maia. (2023) Unravelling the landscape of Cannabis craving pharmacological treatments: a PRISMA-guided review of evidence. International Review of Psychiatry 0:0, pages 1-16.
Read now
Benedikt Bernd Claus, Norbert Scherbaum, Michael Specka, Patrik Roser & Udo Bonnet. (2023) Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes?. Journal of Psychoactive Drugs 0:0, pages 1-12.
Read now
Rick Csiernik & Maeghan Pirie. (2023) A primer on sleeping, dreaming, and psychoactive agents. Journal of Social Work Practice in the Addictions 0:0, pages 1-21.
Read now
Rick Csiernik & Maeghan Pirie. (2023) A primer on sleeping, dreaming, and psychoactive agents. Journal of Social Work Practice in the Addictions 23:1, pages 3-23.
Read now
Julen Marín, Xabier Pérez de Mendiola, Sergio Fernández & Juan Pablo Chart. (2021) Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic. Journal of Addictive Diseases 39:4, pages 579-584.
Read now
Osnat C. Melamed, Tanya S. Hauck, Leslie Buckley, Peter Selby & Benoit H. Mulsant. (2020) COVID-19 and persons with substance use disorders: Inequities and mitigation strategies. Substance Abuse 41:3, pages 286-291.
Read now
Morohunfolu Akinnusi & Ali A. El Solh. (2019) Drug treatment strategies for insomnia in patients with post-traumatic stress disorder. Expert Opinion on Pharmacotherapy 20:6, pages 691-699.
Read now

Articles from other publishers (112)

Veronica O’Neill, Nektarios Karanikas, Adem Sav & Patricia Murphy. (2023) Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews. Workplace Health & Safety 71:9, pages 400-410.
Crossref
Sören Lauff, Frank Petzke, Silviu Brill, Leonie Schouten, Mary‐Ann Fitzcharles, John X. Pereira & Winfried Häuser. (2023) Face validity of the ICD ‐10 criteria of substance abuse and dependence for patients prescribed cannabis‐based medicines for chronic pain—A survey of pain medicine physicians in Canada, Germany and Israel . European Journal of Pain 27:5, pages 588-601.
Crossref
Alan D. BellCaroline MacCallum, Shari MargoleseZach WalshPatrick WrightPaul J. DaeninckEnrico MandarinoGary Lacasse, Jagpaul Kaur DeolLauren de FreitasMichelle St. Pierre, Lynne Belle-IsleMarilou GagnonSian BevanTatiana SanchezStephanie ArltMax Monahan-EllisonJames O'HaraMichael BoivinCecilia Costiniuk, Nancy Chow, Rob Sealey & Lynda Balneaves. (2023) Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research.
Crossref
Ruibin Lu. (2023) Marijuana Policies in Drug Treatment Courts. Journal of Drug Issues, pages 002204262311637.
Crossref
Shalini Shah, Eric S Schwenk, Rakesh V Sondekoppam, Hance Clarke, Mark Zakowski, Rachel S Rzasa-Lynn, Brent Yeung, Kate Nicholson, Gary Schwartz, W Michael Hooten, Mark Wallace, Eugene R Viscusi & Samer Narouze. (2023) ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Regional Anesthesia & Pain Medicine 48:3, pages 97-117.
Crossref
L. Johnson-Ferguson & M. Di Forti. (2021) From heavy cannabis use to psychosis: is it time to take action?. Irish Journal of Psychological Medicine 40:1, pages 13-18.
Crossref
Seth D. Springer, Rachel K. Spooner, Mikki Schantell, Yasra Arif, Michaela R. Frenzel, Jacob A. Eastman & Tony W. Wilson. (2021) Regular recreational Cannabis users exhibit altered neural oscillatory dynamics during attention reorientation. Psychological Medicine 53:4, pages 1205-1214.
Crossref
A.A.A. Kayode, S. Adrish, A. Muhammad, R. Amin, D. Muhammad, Z. Rida, G.O. Alabi, G.F. Okumede & O.T. Kayode. (2023) Therapeutic Uses of Medical Cannabis: An Overview of its Functions in Disease Management. Journal of Medical Sciences 23:1, pages 32-39.
Crossref
A.A.A. Kayode, S. Adrish, A. Muhammad, R. Amin, D. Muhammad, Z. Rida, G.O. Alabi, G.F. Okumede & O.T. Kayode. (2023) Therapeutic Uses of Medical Cannabis: An Overview of its Functions in Disease Management. Journal of Medical Sciences 23:1, pages 24-31.
Crossref
Abigail L. Tuvel, Evan A. Winiger & J. Megan Ross. (2023) A Review of the Effects of Adolescent Cannabis Use on Physical Health. Child and Adolescent Psychiatric Clinics of North America 32:1, pages 85-105.
Crossref
J. Cobb Scott. (2023) Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development. Child and Adolescent Psychiatric Clinics of North America 32:1, pages 21-42.
Crossref
Ana I Fraguas-Sánchez & Ana I. Torres-Suárez. 2023. Current Applications, Approaches, and Potential Perspectives for Hemp. Current Applications, Approaches, and Potential Perspectives for Hemp 407 445 .
Suraj K. Nayak, Manoja K. Majhi, Bikash K. Pradhan, Indranil Banerjee, Satyapriya Mohanty & Kunal Pal. 2023. Advanced Methods in Biomedical Signal Processing and Analysis. Advanced Methods in Biomedical Signal Processing and Analysis 61 85 .
James Rachal, Christian C. Schrader, April Schindler & Veronica Ridpath. 2023. Veteran and Military Mental Health. Veteran and Military Mental Health 303 328 .
Kirsten J. Braatveit, Jörg Assmus & Oddbjørn Hove. (2022) Exploring the predictive properties of the Hayes Ability Screening Index subtest background information in identifying individuals with MBID among in-patients with SUD. Frontiers in Psychiatry 13.
Crossref
Mohammad Razban, Aristomenis K. Exadaktylos, Vincent Della Santa & Eric P. Heymann. (2022) Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department. International Journal of Emergency Medicine 15:1.
Crossref
Berta Ramos, Ana Filipa Santos Martins & Eva Sofia Lima Osório. (2022) Psychotic Cannabis Withdrawal: A Clinical Case. Cureus.
Crossref
Loic Durandel, Stéphane Sanchez, Fabienne Amiot-Chapoutot, Marianne Dacunka, Florian Raoul, Laurent Chapoutot & Aurélie Marchais. (2022) Syndrome coronarien aigu et consommation de cannabis ; étude monocentrique rétrospective au Centre Hospitalier de Troyes. Annales de Cardiologie et d'Angéiologie 71:5, pages 252-258.
Crossref
Larry KeenIIII, Arlener D. Turner, Lauren George & Kimberly Lawrence. (2022) Cannabis use disorder severity and sleep quality among undergraduates attending a Historically Black University. Addictive Behaviors 134, pages 107414.
Crossref
Daniele Lana, Elisa Landucci, Costanza Mazzantini, Giada Magni, Domenico Edoardo Pellegrini-Giampietro & Maria Grazia Giovannini. (2022) The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation. International Journal of Molecular Sciences 23:20, pages 12144.
Crossref
Konstantin N. Zabegalov, David S. Galstyan, Tatyana O. Kolesnikova, Yurii M. Kositsyn, Mariya A. Gubaidullina, Gleb O. Maslov, Konstantin A. Demin, Sergey L. Khatsko & Allan V. Kalueff. (2022) Modeling the drug withdrawal syndrome in zebrafish (<i>Danio rerio</i>). Reviews on Clinical Pharmacology and Drug Therapy 20:2, pages 185-191.
Crossref
Udo Bonnet, Thorsten BordaNorbert ScherbaumMichael Specka. (2022) Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction. Cannabis and Cannabinoid Research 7:5, pages 670-676.
Crossref
Ryan M. Sullivan, Alexander L. WallaceElizabeth A. StinsonKarina V. MontotoChristine M. KaiverNatasha E. WadeKrista M. Lisdahl. (2022) Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults. Cannabis and Cannabinoid Research 7:5, pages 690-699.
Crossref
Jordan A. Gette, Kevin R. McKenna, Nicholas W. McAfee, Julie A. Schumacher, Jefferson D. Parker & Deborah Konkle‐Parker. (2022) Users of cannabis‐only are less likely to accept brief interventions than other substance use profiles in a sample of people living with HIV/AIDS. The American Journal on Addictions 31:5, pages 447-453.
Crossref
Anees Bahji & David A. Gorelick. (2022) Factors Associated With Past-year and Lifetime Prevalence of Cannabis Withdrawal: A Secondary Analysis. Canadian Journal of Addiction 13:3, pages 14-25.
Crossref
Elif Merve Kurt Tunagur, Ahmet Bulent Yazici, Derya Guzel, Mustafa Tolga Tunagur, Cagatay Ermis, Mehmet Akif Suda & Esra Yazici. (2022) Investigating associations between appetite-regulating hormones, aggression and craving in males with cannabis use disorder. Drug and Alcohol Dependence 238, pages 109577.
Crossref
Justin Kim, Jenna Reitsma & Bridget Parsh. (2022) CBD. Nursing 52:8, pages 10-11.
Crossref
Jessica S. Flannery, Michael C. Riedel, Lauren D. Hill-Bowen, Ranjita Poudel, Katherine L. Bottenhorn, Taylor Salo, Angela R. Laird, Raul Gonzalez & Matthew T. Sutherland. (2022) Altered large-scale brain network interactions associated with HIV infection and error processing. Network Neuroscience 6:3, pages 791-815.
Crossref
Ignacio Badiola, Amit Doshi & Samer Narouze. (2022) Cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia. Regional Anesthesia & Pain Medicine 47:7, pages 437-444.
Crossref
Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C. Arnold & Iain S. McGregor. (2022) Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug and Alcohol Review 41:5, pages 1095-1108.
Crossref
Jason P. Connor, Daniel Stjepanović, Alan J. Budney, Bernard Le Foll & Wayne D. Hall. (2022) Clinical management of cannabis withdrawal. Addiction 117:7, pages 2075-2095.
Crossref
Ashley Y. AlbanoDavid C. LandyRobert J. Teasdall, Alexander E. IslaThomas A. KrupkoRaymond D. WrightEric S. MoghadamianPaul E. MatuszewskiArun Aneja. (2022) Is the Presence of a Psychiatric Disorder Associated With More Aggressive Management of Compartment Syndrome?. Journal of Orthopaedic Trauma 36:7, pages e283-e288.
Crossref
Jessica S. Flannery, Michael C. Riedel, Taylor Salo, Lauren D. Hill-Bowen, Ranjita Poudel, Ashley R. Adams, Angela R. Laird, Raul Gonzalez & Matthew T. Sutherland. (2021) Interactive Effects of HIV Infection and Cannabis Use on Insula Subregion Functional Connectivity. Journal of Neuroimmune Pharmacology 17:1-2, pages 289-304.
Crossref
Sam Craft, Jason A. Ferris, Monica J. Barratt, Larissa J. Maier, Michael T. Lynskey, Adam R. Winstock & Tom P. Freeman. (2021) Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis. Psychopharmacology 239:5, pages 1349-1357.
Crossref
Galen Missig, Niyati Mehta, James O. Robbins, Cameron H. Good, Christos Iliopoulos-Tsoutsouvas, Alex Makriyannis, Spyros P. Nikas, Jack Bergman, William A. Carlezon & Carol A. Paronis. (2022) Altered sleep during spontaneous cannabinoid withdrawal in male mice. Behavioural Pharmacology 33:2&3, pages 195-205.
Crossref
Eulla Keimili Fernandes Ferreira CavalheiroAna Beatriz CostaDaniéle Hendler SallaMariella Reinol da SilvaTalita Farias MendesLarissa Espindola da SilvaCristini da Rosa TurattiRafael Mariano de BitencourtGislaine Tezza Rezin. (2022) Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target . Cannabis and Cannabinoid Research 7:2, pages 135-151.
Crossref
Ahmet Bulent Yazici, Derya Guzel, Elif Merve Kurt, Betul Turkmen & Esra Yazici. (2021) Klotho, BDNF, NGF, GDNF Levels and Related Factors in Withdrawal Period in Chronic Cannabinoid Users. Indian Journal of Clinical Biochemistry 37:2, pages 139-148.
Crossref
American Psychiatric Association. 2022. Diagnostic and Statistical Manual of Mental Disorders. Diagnostic and Statistical Manual of Mental Disorders.
Steven K. Erickson & Michelle L. Vorwerk. (2022) A perspective review of cannabis use and sexual offenses. Behavioral Sciences & the Law 40:2, pages 225-238.
Crossref
Dorothy Wallis, J. Douglas Coatsworth, Jeremy Mennis, Nathaniel R. Riggs, Nikola Zaharakis, Michael A. Russell, Aaron R. Brown, Stephanie Rayburn, Aubrie Radford, Christopher Hale & Michael J. Mason. (2022) Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International Journal of Environmental Research and Public Health 19:3, pages 1850.
Crossref
Pablo Romero-Sanchiz, Ioan T. Mahu, Sean P. Barrett, Joshua P. Salmon, Mohammed Al-Hamdani, Jennifer E. Swansburg & Sherry H. Stewart. (2022) Craving and emotional responses to trauma and cannabis cues in trauma-exposed cannabis users: Influence of PTSD symptom severity. Addictive Behaviors 125, pages 107126.
Crossref
Krzysztof Laudanski & Justin Wain. (2022) Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. Journal of Clinical Medicine 11:3, pages 558.
Crossref
Jordi Pérez Martínez. (2022) Aspectos prácticos de la elección del producto y la titulación con cannabis medicinal para el dolor crónico. Revista de la Sociedad Española del Dolor.
Crossref
Fan-Hsuan Kung, Hung-Yi Lin, Yueh-Ming Tai, Hsin-An Chang, Hai-Yu Chiao, Yu-Chieh Huang & Nian-Sheng Tzeng. (2022) Brexpiprazole in the Treatment of Cannabis Withdrawal Psychotic Disorder. American Journal of Therapeutics 29:4, pages 492-493.
Crossref
Jolanta B. Zawilska, Katarzyna Kuczyńska, Jessica Bratzu & Liana Fattore. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1323 1353 .
Heather Murray & Thida Thant. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice 153 163 .
Oybek Nazarov & Guohua Li. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1519 1532 .
Lynnette Nathalie Lyzwinski & Mark J. Eisenberg. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 721 741 .
Dhruti Patel. 2022. Addiction Medicine. Addiction Medicine 33 40 .
John A. R. Grimaldi, John Bodnar, Daniel R. Lavin, Michael L. McLaughlin, J. J. Rasimas & Kenneth Ashley. 2022. HIV Psychiatry. HIV Psychiatry 235 287 .
Oybek Nazarov & Guohua Li. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 14 .
Lynnette Nathalie Lyzwinski & Mark J. Eisenberg. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 21 .
Lynnette Nathalie Lyzwinski & Mark J. Eisenberg. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 21 .
Armin Čulić, Branko Bregar & Mirna Macur. (2021) Raba konoplje v medicinske namene. Obzornik zdravstvene nege 55:4.
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 451 536 .
Kevin M. Takakuwa & Raquel M. Schears. (2021) The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review. International Journal of Emergency Medicine 14:1.
Crossref
Antistio Aviz-Amador, Neyder Contreras-Puentes & Jairo Mercado-Camargo. (2021) Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors. Computational Biology and Chemistry 95, pages 107590.
Crossref
John Howard, Steven Wurzelbacher, Jamie Osborne, Jennifer Wolf, John Ruser & Raji Chadarevian. (2021) Review of cannabis reimbursement by workers’ compensation insurance in the U.S. and Canada. American Journal of Industrial Medicine 64:12, pages 989-1001.
Crossref
Anees Bahji, Arthi Chinna Meyyappan, Emily R Hawken & Philip G. Tibbo. (2021) Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. International Journal of Drug Policy 97, pages 103295.
Crossref
Katie MacCamy & Daniel Hu. (2020) Dexmedetomidine for Treatment of Delayed Peak Symptoms of Cannabis Withdrawal Syndrome: A Case Report. Hospital Pharmacy 56:5, pages 462-465.
Crossref
Rose Schrott, Susan K Murphy, Jennifer L Modliszewski, Dillon E King, Bendu Hill, Nilda Itchon-Ramos, Douglas Raburn, Thomas Price, Edward D Levin, Ryan Vandrey, David L Corcoran, Scott H Kollins & John T Mitchell. (2021) Refraining from use diminishes cannabis-associated epigenetic changes in human sperm. Environmental Epigenetics 7:1.
Crossref
Lara N. Coughlin, Mark A. Ilgen, Mary Jannausch, Maureen A. Walton & Kipling M. Bohnert. (2021) Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain. Addiction 116:8, pages 2067-2075.
Crossref
Megan E. Cooke, Jodi M. Gilman, Erin Lamberth, Natali Rychik, Brenden Tervo-Clemmens, A. Eden Evins & Randi M. Schuster. (2021) Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. Frontiers in Psychiatry 12.
Crossref
Ivett E. Ortega-Mora, Ulises Caballero-Sánchez, Talía V. Román-López, Cintia B. Rosas-Escobar, Mónica Méndez-Díaz, Oscar E. Prospéro-García & Alejandra E. Ruiz-Contreras. (2021) The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence. Journal of the International Neuropsychological Society 27:6, pages 520-532.
Crossref
Andrew J. Kesner & David M. Lovinger. (2021) Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings. Journal of Neurochemistry 157:5, pages 1674-1696.
Crossref
Mary Frances Mullins. (2021) Cannabis dabbing. Nursing 51:5, pages 46-50.
Crossref
Sara J. Hyland, Kara K. Brockhaus, William R. Vincent, Nicole Z. Spence, Michelle M. Lucki, Michael J. Howkins & Robert K. Cleary. (2021) Perioperative Pain Management and Opioid Stewardship: A Practical Guide. Healthcare 9:3, pages 333.
Crossref
Gregor Genrich, Céline Zeller & Hans Jörg Znoj. (2021) Interactions of protective behavioral strategies and cannabis use motives: An online survey among past-month users. PLOS ONE 16:3, pages e0247387.
Crossref
Manuela Mazza. (2021) Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series. Journal of Cannabis Research 3:1.
Crossref
Zeinab Breijyeh, Buthaina Jubeh, Sabino A. Bufo, Rafik Karaman & Laura Scrano. (2021) Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. Toxins 13:2, pages 117.
Crossref
Gregg Joseph Montalto, Elizabeth G. Cius & Maria H. Rahmandar. (2021) Cannabinoids and the Adolescent Patient: A Pragmatic Guide for Pediatric Practitioners. Pediatric Annals 50:2.
Crossref
Mona Yaser Alsheikh. (2021) Post-Acute Withdrawal Syndrome: The Major Cause of Relapse among Psychoactive Substances Addicted Users. Archives Of Pharmacy Practice 12:4, pages 91-97.
Crossref
Yasir Rehman, Amreen Saini, Sarina Huang, Emma Sood, Ravneet Gill & Sezgi Yanikomeroglu. (2021) Cannabis in the management of PTSD: a systematic review. AIMS Neuroscience 8:3, pages 414-434.
Crossref
Asim Kichloo, Michael Albosta, Michael Aljadah, Zain El-Amir, Ghazaleh Goldar, Muhammed Zatmar Khan, Dushyant Singh Dahiya, Srilakshmi Vallabhaneni, Farah Wani & Jagmeet Singh. (2021) Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility. SAGE Open Medicine 9, pages 205031212110009.
Crossref
Karim S. Ladha, Alexander McLaren-Blades, Akash Goel, Michael J. Buys, Paul Farquhar-Smith, Simon Haroutounian, Yuvaraj Kotteeswaran, Kwesi Kwofie, Bernard Le Foll, Nicholas J. Lightfoot, Joel Loiselle, Hamish Mace, Judith Nicholls, Aviva Regev, Leiv Arne Rosseland, Harsha Shanthanna, Avinash Sinha, Ainsley Sutherland, Rob Tanguay, Sherry Yafai, Martha Glenny, Paul Choi, Salima S.J. Ladak, Timothy Sean Leroux, Ian Kawpeng, Bana Samman, Rajbir Singh & Hance Clarke. (2021) Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process. British Journal of Anaesthesia 126:1, pages 304-318.
Crossref
Richard Alecsander Reichert, Kallinca Merillen Silveira, Fernanda Machado Lopes & Denise De Micheli. 2021. Behavior Analysis and Substance Dependence. Behavior Analysis and Substance Dependence 3 20 .
Jolanta B. Zawilska, Katarzyna Kuczyńska, Jessica Bratzu & Liana Fattore. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1 31 .
Samer N. Narouze, Caroline A. MacCallum & Lauren de Freitas. 2021. Cannabinoids and Pain. Cannabinoids and Pain 313 316 .
Jonathan Ek, William Jacobs, Brett Kaylor & W. Vaughn McCall. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep 163 171 .
Benedikt Bernd Claus, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano & Udo Bonnet. (2020) Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?. Frontiers in Psychiatry 11.
Crossref
Samer Narouze, Natalie Strand & Priodarshi Roychoudhury. (2020) Cannabinoids-based Medicine Pharmacology, Drug Interactions, and Perioperative Management of Surgical Patients. Advances in Anesthesia 38, pages 167-188.
Crossref
John Howard & Jamie Osborne. (2020) Cannabis and work: Need for more research. American Journal of Industrial Medicine 63:11, pages 963-972.
Crossref
Yael Dagan & Joel Yager. (2020) Cannabis and Complex Posttraumatic Stress Disorder. Journal of Nervous & Mental Disease 208:8, pages 619-627.
Crossref
B. Kraft & W. Stromer. (2020) Der Einfluss von Cannabis und Cannabinoiden auf Anästhesie und Analgesie in der perioperativen PhaseThe effects of cannabis and cannabinoids on anesthesia and analgesia during the perioperative period. Der Schmerz 34:4, pages 314-318.
Crossref
Santosh Kumar, Vikas Verma, Umesh Kushwaha, Emilie J. Calvello Hynes, Amit Arya & Abhishek Agarwal. (2020) Prevalence and association of depression in in-patient orthopaedic trauma patients: A single centre study in India. Journal of Clinical Orthopaedics and Trauma 11, pages S573-S577.
Crossref
Alexandra B. Moussa-Tooks, Eric R. Larson, Alex F. Gimeno, Emma Leishman, Lisa A. Bartolomeo, Heather B. Bradshaw, John T. Green, Brian F. O’Donnell, Ken Mackie & William P. Hetrick. (2020) Long-Term Aberrations To Cerebellar Endocannabinoids Induced By Early-Life Stress. Scientific Reports 10:1.
Crossref
Jillian E. Halladay, James MacKillop, Catharine Munn, Susan M. Jack & Katholiki Georgiades. (2020) Cannabis Use as a Risk Factor for Depression, Anxiety, and Suicidality. Journal of Addictions Nursing 31:2, pages 92-101.
Crossref
Lesley Taylor, Julie Crockett, Bola Tayo, Daniel Checketts & Kenneth Sommerville. (2020) Abrupt withdrawal of cannabidiol (CBD): A randomized trial. Epilepsy & Behavior 104, pages 106938.
Crossref
Pamela E. Macintyre, Lindy J. Roberts & Christine A. Huxtable. (2019) Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges. Drugs 80:1, pages 9-21.
Crossref
Elizabeth Brooks & Stig Erik Sørheim. 2020. Cannabis in Medicine. Cannabis in Medicine 453 491 .
Matthew Chung & Salahadin Abdi. 2020. Cannabis in Medicine. Cannabis in Medicine 325 343 .
Karim S. LadhaVaruna ManooAli-Faizan VirjiJohn G. HanlonAlexander Mclaren-BladesAkash GoelDuminda N. WijeysunderaLakshmi P. KotraCarlos IbarraMarina EnglesakisHance Clarke. (2019) The Impact of Perioperative Cannabis Use: A Narrative Scoping Review. Cannabis and Cannabinoid Research 4:4, pages 219-230.
Crossref
Marco Echeverria-Villalobos, Alexandre B. Todeschini, Nicoleta Stoicea, Juan Fiorda-Diaz, Tristan Weaver & Sergio D. Bergese. (2019) Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. Journal of Clinical Anesthesia 57, pages 41-49.
Crossref
Nicholas Chadi & Sharon Levy. (2019) What Every Pediatric Gynecologist Should Know About Marijuana Use in Adolescents. Journal of Pediatric and Adolescent Gynecology 32:4, pages 349-353.
Crossref
Yaniv Chocron, Jean-Philippe Zuber & Julien Vaucher. (2019) Cannabinoid hyperemesis syndrome. BMJ, pages l4336.
Crossref
Jaderson Vieira Ferreira, Lenir Cabral Correa, Daniel Castro da Costa & Lorane Izabel da Silva Hage-Melim. 2019. Recent Advances in Cannabinoid Research. Recent Advances in Cannabinoid Research.
Ofir Livne, Dvora Shmulewitz, Shaul Lev-Ran & Deborah S. Hasin. (2019) DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. Drug and Alcohol Dependence 195, pages 170-177.
Crossref
Alicja Lerner & Michael Klein. (2019) Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Communications 1:1.
Crossref
Brian E. Perron, Katlyn R. Holt, Emily Yeagley & Mark Ilgen. (2019) Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain. Drug and Alcohol Dependence 194, pages 401-409.
Crossref
Robert Hämmig, Ulrich W. Preuss & Michael Soyka. 2019. Suchtmedizin. Suchtmedizin 143 175 .
Miriam Schneider, Chris Maria Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus, F. Markus Leweke, Beat Lutz, Liane Paul, Oliver Pogarell, Ulrich Preuss, Michael Schäfer, Sophia Schmieder, Roland Simon, Martin Storr & Eva Hoch. 2019. Cannabis: Potenzial und Risiko. Cannabis: Potenzial und Risiko 65 264 .
Daryl BlaneyJr.Jr., Annise K. Jackson, Ozan Toy, Anna Fitzgerald & Joanna Piechniczek-Buczek. 2019. Substance Use and the Acute Psychiatric Patient. Substance Use and the Acute Psychiatric Patient 125 144 .
S. Alex Sidelnik & Theodore I. Benzer. 2019. Substance Use and the Acute Psychiatric Patient. Substance Use and the Acute Psychiatric Patient 69 81 .
Charlene Joseph, Olawale Ojo, Olusegun Popoola, Heela Azizi, Tasmia Khan, Orin Pramanik, Alexa Kahn, Shazia Chaudhry, Dina Rimawi, Megha Singh, Ali Mallick, Sharon Paul, Chiedozie Ojimba & Ayodeji Jolayemi. (2018) A case of brief psychosis upon cannabis withdrawal. MOJ Addiction Medicine & Therapy 5:6.
Crossref
Thomas M. ClarkJessica M. JonesAlexis G. HallSara A. TabnerRebecca L. Kmiec. (2018) Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users . Cannabis and Cannabinoid Research 3:1, pages 259-271.
Crossref
Ana Isabel Fraguas-Sánchez & Ana Isabel Torres-Suárez. (2018) Medical Use of Cannabinoids. Drugs 78:16, pages 1665-1703.
Crossref
Joao P. De Aquino, Mohamed Sherif, Rajiv Radhakrishnan, John D. Cahill, Mohini Ranganathan & Deepak C. D’Souza. (2018) The Psychiatric Consequences of Cannabinoids. Clinical Therapeutics 40:9, pages 1448-1456.
Crossref
Sandra J. Japuntich, Kimberly A. Arditte Hall, Celina M. Joos, Ann M. Rasmusson & Suzanne L. Pineles. (2018) Methods to reduce false reporting of substance abstinence in clinical research. International Journal of Methods in Psychiatric Research 27:3.
Crossref
G. M. Mandolini, M. Lazzaretti, A. Pigoni, L. Oldani, G. Delvecchio & P. Brambilla. (2018) Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiology and Psychiatric Sciences 27:4, pages 327-335.
Crossref
Janna Cousijn & A. C. K. van Duijvenvoorde. (2018) Cognitive and Mental Health Predictors of Withdrawal Severity During an Active Attempt to Cut Down Cannabis Use. Frontiers in Psychiatry 9.
Crossref
Christina A Brezing & Frances R Levin. (2017) The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology 43:1, pages 173-194.
Crossref
Lauren Hood. 2018. Animal Models for Examining Social Influences on Drug Addiction. Animal Models for Examining Social Influences on Drug Addiction 171 200 .